| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |